Payload Information
General Information of This Payload
Payload ID | PAY0OYHUV |
|||||
---|---|---|---|---|---|---|
Name | DM1 derivative 15 |
|||||
Synonyms |
DM1 derivative 15
Click to Show/Hide
|
|||||
Target(s) | Microtubule (MT) | |||||
Formula | C32H44ClN3O9 |
|||||
Isosmiles | CNC(C)C(=O)OC1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/C(OC)C2(O)CC(OC(=O)N2)C(C)C2OC12C |
|||||
InChI |
InChI=1S/C32H44ClN3O9/c1-17-10-9-11-24(42-8)32(40)16-23(43-30(39)35-32)18(2)28-31(4,45-28)25(44-29(38)19(3)34-5)15-26(37)36(6)21-13-20(12-17)14-22(41-7)27(21)33/h9-11,13-14,18-19,23-25,28,34,40H,12,15-16H2,1-8H3,(H,35,39)/b11-9-,17-10-
|
|||||
Pharmaceutical Properties | Molecule Weight |
650.169 |
Polar area |
148.19 |
||
Complexity |
45 |
xlogp Value |
3.2755 |
|||
Heavy Count |
45 |
Rot Bonds |
5 |
|||
Hbond acc |
10 |
Hbond Donor |
3 |
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
PSMA-15 [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
3.80 nM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
Cells were seeded in PDL-coated 96 well plates at 375 for MMT/hEGFRvIII, 1500 for U251/hEGFRvIII, 2000 for HEK293/hEGFRvIII, or 3000 for C4-2, PC3, and T47D cells per well in complete growth media and grown overnight.
|
||||
In Vitro Model | Lymph node metastasis of prostate carcinoma | LNCaP C4-2 cells | CVCL_4782 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.